Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 206 publications
Canine Mdr1 Knockout MDCK Cells Reliably Estimate Human Small Intestinal Permeability (Peff) and Fraction Absorbed (fa).
Journal: Molecular pharmaceutics
Published: September 07, 2025
Spleen Tyrosine Kinase Inhibition Mitigates Hemin-Induced Thromboinflammation in an Organ-Specific Manner in Sickle Cell Mice.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: August 15, 2025
Equine Metabolism of Voxelotor and Its Impact on Hematological Indices: A Doping Control Perspective.
Journal: Drug testing and analysis
Published: June 12, 2025
Voxelotor (Oxbryta) Binds Multiple Hemoglobin Sites and Influences Protein Structure.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2025
Effect of dalcetrapib, voxelotor and their combination on red blood cell deformability and sickling in sickle cell disease.
Journal: Clinical hemorheology and microcirculation
Published: April 21, 2025
Osivelotor for the treatment of sickle cell disease.
Journal: Expert opinion on pharmacotherapy
Published: April 03, 2025
Discovery of Osivelotor (GBT021601): A Potent, Next-Generation Sickle Hemoglobin Polymerization Inhibitor.
Journal: ACS medicinal chemistry letters
Published: February 11, 2025
Rapid withdrawal of voxelotor can precipitate sickle cell disease related crisis.
Journal: Annals of hematology
Published: January 27, 2025
Grandchildren of GRNDaD: Shifts in disease-modifying therapy at the adolescent transition in sickle cell disease.
Journal: British journal of haematology
Published: January 20, 2025
Last Updated: 10/31/2025